ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable) — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(90 sites)
Belgium
Grand Hopital de Charleroi - site Notre Dame, Charleroi Groupe Jolimont - Hôpital De Jolimont, Haine-Saint-Paul CHU UCL NAMUR - Site STE. ELISABETH, Namur Clinique Saint Pierre, Ottignies France
Institut Sainte Catherine, Avignon Last updated September 2024